301 related articles for article (PubMed ID: 24395761)
1. Towards nanomedicines for neuroAIDS.
Sagar V; Pilakka-Kanthikeel S; Pottathil R; Saxena SK; Nair M
Rev Med Virol; 2014 Mar; 24(2):103-24. PubMed ID: 24395761
[TBL] [Abstract][Full Text] [Related]
2. Nano-ART and NeuroAIDS.
Das MK; Sarma A; Chakraborty T
Drug Deliv Transl Res; 2016 Oct; 6(5):452-72. PubMed ID: 27137528
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
Varghese NM; Senthil V; Saxena SK
J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
[TBL] [Abstract][Full Text] [Related]
4. Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.
Nair M; Jayant RD; Kaushik A; Sagar V
Adv Drug Deliv Rev; 2016 Aug; 103():202-217. PubMed ID: 26944096
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS.
Singh G; Pai RS; Mustafa S
Crit Rev Ther Drug Carrier Syst; 2015; 32(6):503-33. PubMed ID: 26559551
[TBL] [Abstract][Full Text] [Related]
6. Nano-based drug delivery system: a smart alternative towards eradication of viral sanctuaries in management of NeuroAIDS.
Aggarwal N; Sachin ; Nabi B; Aggarwal S; Baboota S; Ali J
Drug Deliv Transl Res; 2022 Jan; 12(1):27-48. PubMed ID: 33486689
[TBL] [Abstract][Full Text] [Related]
7. Progress in antiretroviral drug delivery using nanotechnology.
Mallipeddi R; Rohan LC
Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115
[TBL] [Abstract][Full Text] [Related]
8. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
Nabi B; Rehman S; Baboota S; Ali J
AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
[TBL] [Abstract][Full Text] [Related]
9. NanoART, neuroAIDS and CNS drug delivery.
Nowacek A; Gendelman HE
Nanomedicine (Lond); 2009 Jul; 4(5):557-74. PubMed ID: 19572821
[TBL] [Abstract][Full Text] [Related]
10. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
Gupta U; Jain NK
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
[TBL] [Abstract][Full Text] [Related]
11. Nanotherapeutics: emerging competent technology in neuroAIDS and CNS drug delivery.
Saxena SK; Tiwari S; Nair MP
Nanomedicine (Lond); 2012 Jul; 7(7):941-4. PubMed ID: 22846087
[No Abstract] [Full Text] [Related]
12. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
Muthu MS; Singh S
Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology: a magic bullet for HIV AIDS treatment.
Kumar L; Verma S; Prasad DN; Bhardwaj A; Vaidya B; Jain AK
Artif Cells Nanomed Biotechnol; 2015 Apr; 43(2):71-86. PubMed ID: 24564348
[TBL] [Abstract][Full Text] [Related]
14. Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS.
Kumar S; Maurya VK; Dandu HR; Bhatt ML; Saxena SK
Biomol Concepts; 2018 May; 9(1):33-42. PubMed ID: 29742062
[TBL] [Abstract][Full Text] [Related]
15. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
Wong HL; Chattopadhyay N; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):503-17. PubMed ID: 19914319
[TBL] [Abstract][Full Text] [Related]
17. Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.
Edagwa BJ; Zhou T; McMillan JM; Liu XM; Gendelman HE
Curr Med Chem; 2014; 21(36):4186-98. PubMed ID: 25174930
[TBL] [Abstract][Full Text] [Related]
18. Sustained-release nanoART formulation for the treatment of neuroAIDS.
Jayant RD; Atluri VS; Agudelo M; Sagar V; Kaushik A; Nair M
Int J Nanomedicine; 2015; 10():1077-93. PubMed ID: 25709433
[TBL] [Abstract][Full Text] [Related]
19. Chapter 12- Brain as an HIV sequestered site: Use of nanoparticles as a therapeutic option.
Destache CJ
Prog Brain Res; 2009; 180():225-33. PubMed ID: 20302837
[TBL] [Abstract][Full Text] [Related]
20. New hope for eradication of HIV from the body: the role of polymeric nanomedicines in HIV/AIDS pharmacotherapy.
Lenjisa JL; Woldu MA; Satessa GD
J Nanobiotechnology; 2014 Mar; 12():9. PubMed ID: 24655921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
